Senti Bio (NASDAQ: SNTI) has announced the appointment of entrepreneurial leader and investor Bryan Baum to its board of directors (BOD). Mr. Baum is the co-founder and managing partner of K5 Global. His portfolio...
Iovance Biotherapeutics (NASDAQ: IOVA) has announced the appointment of Corleen Roche as chief financial officer (CFO), effective August 6, 2025. Ms. Roche brings three decades of biotech and life sciences industry...
Quince Therapeutics (NASDAQ: QNCX) has announced the appointment of leading immunologist, Hassan Abolhassani, MD, PhD, to its scientific advisory board (SAB). Dr. Abolhassani currently serves as assistant professor of...
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) has announced the appointment of Veet Misra, PhD, as chief financial officer (CFO), and Eric Huang as senior vice president (SVP) of global corporate development and...
Allarity Therapeutics (NASDAQ: ALLR) has announced the appointment of Jeff Ervin as chief financial officer (CFO), succeeding Alexander Epshinsky, who will remain involved during the transition period. Mr. Ervin brings...
Dr. Robert T. Foster Her Excellency the Right Honourable Mary Simon, Governor General of Canada, has announced 83 new appointments to the Order of Canada, including Robert Thomas Foster, PharmD, PhD, C.M., A.O.E. Dr...
Medicus Pharma (NASDAQ: MDCX) has announced the appointment of Andrew Smith as chief operating officer (COO). A seasoned leader in asset management and financial operations with more than three decades of experience, Mr...
Ladenburg Thalmann announced that Kevin DeGeeter has rejoined the firm as a managing director in its equity research department, effective June 2025. In this role, Mr. DeGeeter will lead equity research coverage of...
Annexon (NASDAQ: ANNX) announced the appointment of Lloyd Clark, MD, as SVP, ophthalmology strategy and innovation. Dr. Clark brings more than 25 years of experience in treating retinal diseases and advancing novel...
Avalo Therapeutics (NASDAQ: AVTX) has announced the appointment of Rita Jain, MD, to its board of directors (BOD). To this role, Dr. Jain, a rheumatologist, brings more than two decades of leadership in...